Hybridoma-derived monoclonal antibodies targeting a viscumin epitope: a novel approach for detection and potential therapeutic applications
American Journal of Clinical and Experimental Immunology · 2025
DOI: 10.62347/dnnl4431 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2025. Verfasst von Jamil Zargan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Imam Hossein Comprehensive University Tehran, Iran. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Imam Hossein Comprehensive University Tehran, Iran.
Zitieren
APA
Zargan, J., Zadeh, M. S. O., Noghabi, H. D., & Hajizade, A. (2025). Hybridoma-derived monoclonal antibodies targeting a viscumin epitope: a novel approach for detection and potential therapeutic applications. American Journal of Clinical and Experimental Immunology. https://doi.org/10.62347/dnnl4431
Vancouver
Zargan J, Zadeh MSO, Noghabi HD, Hajizade A. Hybridoma-derived monoclonal antibodies targeting a viscumin epitope: a novel approach for detection and potential therapeutic applications. American Journal of Clinical and Experimental Immunology. 2025. doi:10.62347/dnnl4431
BibTeX
@article{Zargan2025,
author = {Zargan, Jamil and Zadeh, Mohammad Sadegh Odeh and Noghabi, Hossein Delavari and Hajizade, Abbas},
title = {Hybridoma-derived monoclonal antibodies targeting a viscumin epitope: a novel approach for detection and potential therapeutic applications},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2025},
doi = {10.62347/dnnl4431}
}
EUVIMED